Although these studies support a functional role of FAP+ cells in immunosurveillance, the targeting of FAP+ CAFs, via adoptive transfer of FAP-targeted chimeric antigen receptor (CAR) T cells, can also suppress pancreatic cancer growth in mice by suppressing tumor angiogenesis (Lo et al., 2015). The gene discussed is FAP; the disease is pancreatic neoplasm.